Credit Suisse’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $574K | Hold |
11,845
| – | – | ﹤0.01% | 2574 |
|
|
2023
Q4 | $635K | Buy |
11,845
+969
| +9% | +$49K | ﹤0.01% | 2609 |
|
|
2023
Q3 | $637K | Sell |
10,876
-619
| -5% | -$38.7K | ﹤0.01% | 2555 |
|
|
2023
Q2 | $725K | Buy |
11,495
+1,675
| +17% | +$107K | ﹤0.01% | 2594 |
|
|
2023
Q1 | $618K | Buy |
9,820
+3
| +0% | +$179 | ﹤0.01% | 2630 |
|
|
2022
Q4 | $522K | Sell |
9,817
-10,033
| -51% | -$544K | ﹤0.01% | 2754 |
|
|
2022
Q3 | $1.11M | Sell |
19,850
-470
| -2% | -$31.1K | ﹤0.01% | 2250 |
|
|
2022
Q2 | $1.47M | Sell |
20,320
-4,635
| -19% | -$345K | ﹤0.01% | 2120 |
|
|
2022
Q1 | $1.98M | Sell |
24,955
-26,870
| -52% | -$2.42M | ﹤0.01% | 2087 |
|
|
2021
Q4 | $5.25M | Buy |
51,825
+40,833
| +371% | +$4.07M | ﹤0.01% | 1979 |
|
|
2021
Q3 | $1.01M | Sell |
10,992
-4,176
| -28% | -$402K | ﹤0.01% | 3330 |
|
|
2021
Q2 | $1.55M | Sell |
15,168
-546
| -3% | -$54.8K | ﹤0.01% | 3049 |
|
|
2021
Q1 | $1.53M | Sell |
15,714
-910
| -5% | -$82.8K | ﹤0.01% | 3009 |
|
|
2020
Q4 | $1.28M | Buy |
16,624
+5,768
| +53% | +$446K | ﹤0.01% | 3145 |
|
|
2020
Q3 | $800K | Sell |
10,856
-95
| -0.9% | -$7.62K | ﹤0.01% | 3098 |
|
|
2020
Q2 | $804K | Sell |
10,951
-2,707
| -20% | -$212K | ﹤0.01% | 3031 |
|
|
2020
Q1 | $790K | Buy |
13,658
+2,524
| +23% | +$176K | ﹤0.01% | 2833 |
|
|
2019
Q4 | $874K | Sell |
11,134
-3,105
| -22% | -$229K | ﹤0.01% | 3230 |
|
|
2019
Q3 | $974K | Sell |
14,239
-31,957
| -69% | -$2.15M | ﹤0.01% | 3031 |
|
|
2019
Q2 | $3.67M | Sell |
46,196
-7,330
| -14% | -$581K | ﹤0.01% | 1992 |
|
|
2019
Q1 | $4.49M | Buy |
53,526
+27,415
| +105% | +$2.86M | ﹤0.01% | 1791 |
|
|
2018
Q4 | $3.07M | Sell |
26,111
-8,235
| -24% | -$952K | ﹤0.01% | 1936 |
|
|
2018
Q3 | $4.14M | Buy |
34,346
+18,018
| +110% | +$2.24M | ﹤0.01% | 1816 |
|
|
2018
Q2 | $1.88M | Buy |
16,328
+810
| +5% | +$88.6K | ﹤0.01% | 2520 |
|
|
2018
Q1 | $1.33M | Buy |
15,518
+1,431
| +10% | +$111K | ﹤0.01% | 2758 |
|
|
2017
Q4 | $1.04M | Sell |
14,087
-1,565
| -10% | -$105K | ﹤0.01% | 2961 |
|
|
2017
Q3 | $903K | Buy |
15,652
+6,881
| +78% | +$407K | ﹤0.01% | 3173 |
|
|
2017
Q2 | $561K | Sell |
8,771
-11,970
| -58% | -$738K | ﹤0.01% | 3076 |
|
|
2017
Q1 | $1.2M | Sell |
20,741
-828
| -4% | -$49.4K | ﹤0.01% | 2727 |
|
|
2016
Q4 | $1.32M | Buy |
21,569
+6,583
| +44% | +$429K | ﹤0.01% | 2804 |
|
|
2016
Q3 | $1.04M | Sell |
14,986
-17,486
| -54% | -$1.15M | ﹤0.01% | 2927 |
|
|
2016
Q2 | $1.81M | Buy |
32,472
+10,316
| +47% | +$622K | ﹤0.01% | 2406 |
|
|
2016
Q1 | $1.35M | Sell |
22,156
-13,570
| -38% | -$799K | ﹤0.01% | 2500 |
|
|
2015
Q4 | $2.28M | Buy |
35,726
+6,070
| +20% | +$394K | ﹤0.01% | 2185 |
|
|
2015
Q3 | $1.99M | Buy |
29,656
+16,182
| +120% | +$1.14M | ﹤0.01% | 2258 |
|
|
2015
Q2 | $921K | Sell |
13,474
-1,550
| -10% | -$98.4K | ﹤0.01% | 3261 |
|
|
2015
Q1 | $835K | Sell |
15,024
-44,520
| -75% | -$2.28M | ﹤0.01% | 3142 |
|
|
2014
Q4 | $3.05M | Buy |
59,544
+40,652
| +215% | +$2M | ﹤0.01% | 2171 |
|
|
2014
Q3 | $696K | Buy |
18,892
+1,008
| +6% | +$36.4K | ﹤0.01% | 3372 |
|
|
2014
Q2 | $699K | Sell |
17,884
-5,890
| -25% | -$219K | ﹤0.01% | 3580 |
|
|
2014
Q1 | $895K | Sell |
23,774
-18,076
| -43% | -$631K | ﹤0.01% | 3227 |
|
|
2013
Q4 | $1.58M | Buy |
41,850
+25,904
| +162% | +$991K | ﹤0.01% | 2879 |
|
|
2013
Q3 | $692K | Sell |
15,946
-71,832
| -82% | -$2.88M | ﹤0.01% | 3262 |
|
|
2013
Q2 | $3.18M | Buy |
+87,778
| New | +$2.67M | ﹤0.01% | 1933 |
|
Other funds holding USNA
Credit Suisse's USNA Position: Q1 2024 in Review
Credit Suisse held its Usana Health Sciences (USNA) position steady in Q1 2024 at 11,845 shares worth $574K. The position accounts for ﹤0.01% of the portfolio, ranked #2574.
Credit Suisse first reported a position in USNA in Q2 2013 and has held it in 44 quarters since. The position peaked at $5.25M in Q4 2021. 161 funds tracked by Wall St. Rank hold USNA as of Q1 2024.
- Credit Suisse held 11,845 shares of Usana Health Sciences worth $574K as of Q1 2024.
- Credit Suisse left its Usana Health Sciences share count unchanged in Q1 2024.
- Usana Health Sciences made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2574 holding.
- Credit Suisse first reported a position in Usana Health Sciences in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Usana Health Sciences position peaked at $5.25M in Q4 2021.
- 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.